# Ophthalmic and Topical Dosage Form New Animal Drugs; Nystatin, Neomycin, Thiostrepton, and Triamcinolone Acetonide Ointment
> **Food and Drug Administration** · Final rule. · Published 1999-08-06 · Effective 1999-08-06 · 64 FR 42831
## Document
- **Document number:** 99-20254
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 64 FR 42831
- **CFR reference:** 21 CFR 524
- **Publication date:** 1999-08-06
- **Effective date:** 1999-08-06
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Med-Pharmex, Inc. The ANADA provides for use of nystatin, neomycin, thiostrepton, and triamcinolone acetonide vanishing cream base ointment for topical management of dermatologic disorders of dogs and cats.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1999/08/06/99-20254/ophthalmic-and-topical-dosage-form-new-animal-drugs-nystatin-neomycin-thiostrepton-and-triamcinolone)
---
*AI Analytics · CC0 1.0*